60809-801 : Krystexxa 8 mg/ml Intravenous Injection, Solution

Labeler: Crealta Pharmaceuticals LLC
Product Type: Human Prescription Drug
Drug Name:  Krystexxa
Dosage Form: Intravenous Injection, Solution
Application #: BLA125293
Rev. Date: 

NDC Package Codes:

  • 60809-801-01: 1 VIAL IN 1 CARTON (60809‑801‑01) > 1 ML IN 1 VIAL

Active Ingredients:

  • Pegloticase

Dosage Strength:

  • 8 mg/mL

Pharmaceutical Classes:

  • Urate Oxidase [Chemical/Ingredient]
  • Uric Acid-specific Enzyme [EPC]

Related Products:

Based on records with the same trade name.
  • 54396-801 Krystexxa 8 mg/ml Intravenous Injection, Solution by Savient Pharmaceuticals, Inc.
  • 75987-080 Krystexxa 8 mg/ml Intravenous Injection, Solution by Horizon Pharma Inc.


Scan the QR code below to easily reference this data in the future:

NDC 60809-801 QR Code

< Prev: 60809-166Next: 60833-001 >

Related Discussions:

sir can you send me full article of same to below mentioned email...

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA